Med Page Today
AUGUST 12, 2024
(MedPage Today) -- An anti-inflammatory diet was tied to a lower risk for dementia in people ages 60 and older with cardiometabolic diseases, U.K. Biobank data showed. Among people with cardiometabolic diseases including type 2 diabetes, heart.
HCPLive
AUGUST 12, 2024
Mora and Sadreameli join Lungcast to provide a back-to-school health blueprint, including topics like rescue inhalers, vaccination, vaping and air quality.
Science Daily - Heart Disease
AUGUST 12, 2024
Patients with a common heart arrhythmia called Atrial Fibrillation could benefit from future treatments that target inefficiencies in heart cell metabolism, according to a new article.
Med Page Today
AUGUST 12, 2024
(MedPage Today) -- Hyperkalemia in type 2 diabetes occurred less often with GLP-1 receptor agonists in routine care than dipeptidyl peptidase-4 (DPP-4) inhibitors, a large observational study in Sweden showed. Over a median 3.9-month treatment.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
HCPLive
AUGUST 12, 2024
Palopegteriparatide’s approval was based on positive data from the global Phase 2 PaTH Forward and Phase 3 PaTHway trials.
Med Page Today
AUGUST 12, 2024
(MedPage Today) -- In today's modern world, where does primary care fit in? Especially at large academic medical centers like ours, the focus across the institution tends to be on secondary, tertiary, and quaternary care. This is the stuff that.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Circulation
AUGUST 12, 2024
Circulation, Ahead of Print. Aortopathy encompasses a spectrum of conditions predisposing to dilation, aneurysm, dissection, or rupture of the aorta and other blood vessels. Aortopathy is diagnosed commonly in children, from infancy through adolescence, primarily affecting the thoracic aorta, with variable involvement of the peripheral vasculature. Pathogeneses include connective tissue disorders, smooth muscle contraction disorders, and congenital heart disease, including bicuspid aortic valve,
Science Daily - Heart Disease
AUGUST 12, 2024
MRI scans could replace invasive heart tests, as new research shows they can reliably estimate pressures inside the heart to predict if a patient will develop heart failure.
HCPLive
AUGUST 12, 2024
In this interview, Kim speaks about the significance of the FDA approval of neffy for patients who face the threat of anaphylaxis and other severe allergic reactions.
American College of Cardiology
AUGUST 12, 2024
What is the prognostic value of positron emission tomography (PET) in patients with cardiac sarcoidosis?
HCPLive
AUGUST 12, 2024
Cristina Pearse, an MDMA-assisted therapy trial participant, expresses disappointment in the FDA’s decision not to approve MDMA-assisted therapy.
American College of Cardiology
AUGUST 12, 2024
In this episode, Drs. Erin Michos and Steven Nissen discuss newly emerging therapies for elevated Lp(a) management and forthcoming developments in research. Drs. Michos and Nissen highlight the key differences between therapies in late trial stages and discuss upcoming cardiovascular outcome trials.
HCPLive
AUGUST 12, 2024
Adjusted analyses reveal a statistically significantly higher prescription medication cost in patients with RA compared to those without.
Frontiers in Cardiovascular Medicine
AUGUST 12, 2024
BackgroundAcute coronary syndrome (ACS) is a leading cause of morbidity and mortality worldwide. In recent years, ACS has been reported to be associated with age, and the incidence has become more common in younger patients. Previous studies have identified various risk factors that contribute to the stratification of ACS patients. However, it remains unclear whether these risk factors, along with proteomic and clinical characteristics, are applicable to young ACS patients, as they are for middl
HCPLive
AUGUST 12, 2024
A new real-world study suggests tirzepatide provides greater reductions in mortality, cardiovascular risk, and kidney events than GLP-1 receptor agonists in type 2 diabetes.
Frontiers in Cardiovascular Medicine
AUGUST 12, 2024
IntroductionUltrasound is well-established as an imaging modality for diagnostic and interventional purposes. However, the image quality varies with operator skills as acquiring and interpreting ultrasound images requires extensive training due to the imaging artefacts, the range of acquisition parameters and the variability of patient anatomies. Automating the image acquisition task could improve acquisition reproducibility and quality but training such an algorithm requires large amounts of na
HCPLive
AUGUST 12, 2024
An introductory episode for Medical Ethics Unpacked, a monthly multimedia series hosted by medical ethicist Dominic Sisti, PhD, and psychiatrist Steven Levine, MD, exploring ethical issues in contemporary healthcare.
Med Page Today
AUGUST 12, 2024
(MedPage Today) -- The older the patient, the worse the functional outcome tended to be after endovascular thrombectomy (EVT) for an acute ischemic stroke with a large infarct, observational data suggested. Based on a German multicenter registry.
HCPLive
AUGUST 12, 2024
This analysis compared drug survival rates of abrocitinib and dupilumab in the treatment of adults with eczema, with different benefits highlighted for both therapies.
HeartRhythm
AUGUST 12, 2024
Achieving transmural and durable lesions during radiofrequency-based endocardial Ventricular Tachycardia (VT) ablation remains challenging when substrate is located within the septum, the mid-myocardium or the epicardium. In such situations, epicardial ablation, bipolar ablation, half-normal saline infusion, or bailout therapies such as ethanol injection with double-balloon technique1 have been proposed.
HCPLive
AUGUST 12, 2024
Alkhouri explains the value of AGILE 3+ and AGILE 4, reviewing key findings from a recent study applying the scores to NHANES data to estimate MASLD fibrosis and cirrhosis.
American College of Cardiology
AUGUST 12, 2024
The goal of the TRACE-III trial was to demonstrate the efficacy and safety of tenecteplase administered 4.5–24 hours after stroke onset in patients who had had ischemic stroke resulting from large-vessel occlusion, had salvageable tissue, and did not have access to endovascular thrombectomy.
HCPLive
AUGUST 12, 2024
Dr Marcus highlights procedure and safety overview for the port delivery system (PDS).
American College of Cardiology
AUGUST 12, 2024
What are the trends in follow-up after acute myocardial infarction (AMI) and heart failure (HF) hospitalization?
HCPLive
AUGUST 12, 2024
Similar trends were seen in study participants that transitioned from receiving placebo to bimekizumab after study week 16.
American College of Cardiology
AUGUST 12, 2024
Current cardiovascular (CV) guidelines do not incorporate gender identity and hormone status into risk stratification and clinical decision-making. Clinical understanding of gender-affirming hormone therapy (GAHT) on CV health has been limited by a lack of high-quality research.
HCPLive
AUGUST 12, 2024
Maintaining stable HbA1c levels in target ranges reduces Alzheimer Disease risk in older adults with diabetes, emphasizing the importance of personalized glycemic control.
HeartRhythm
AUGUST 12, 2024
Ischemic heart disease (IHD) has been linked to an increased risk of atrial fibrillation (AF). However, data are sparse regarding the role of IHD in AF recurrence after catheter ablation.
HCPLive
AUGUST 12, 2024
Ravulizumab therapy may enable patients with PNH to achieve activity and patient-reported outcomes comparable to the US general population.
Journal of Cardiovascular Pharmacology
AUGUST 12, 2024
Heart failure has always been a prevalent, disabling, and potentially life-threatening disease. For the treatment of heart failure, controlling cardiac remodeling is very important. In recent years, clinical trials have shown that SGLT-2 inhibitors not only excel in lowering glucose levels but also demonstrate favorable cardiovascular protective effects.
HCPLive
AUGUST 12, 2024
The updated pediatric IgAN prediction tool allows clinicians to assess risk of disease progression 1-2 years post-biopsy.
HeartRhythm
AUGUST 12, 2024
Pulsed-field ablation (PFA) of atrial fibrillation (AF) is a new method in clinical practice. Despite a favorable safety profile of PFA in AF ablation, rare cases of renal failure, probably due to hemolysis, have been recently reported.
HCPLive
AUGUST 12, 2024
A panel of dermatologists discuss the heterogeneity of clinical presentations of atopic dermatitis and offer ways to reduce misdiagnosis.
Open Heart
AUGUST 12, 2024
Objectives Sex differences occur in atrial fibrillation (AF), including age at first manifestation, pathophysiology, treatment allocation, complication rates and quality of life. However, optimal doses of cardiovascular pharmacotherapy used in women with AF with or without heart failure (HF) are unclear. We investigated sex-specific associations of beta-blocker and renin–angiotensin system (RAS) inhibitor doses with cardiovascular outcomes in patients with AF or AF with concomitant HF.
Expert insights. Personalized for you.
137 
Let's personalize your content